Page 2 - High Acuity News Today

Research analysts at StockNews.com assumed coverage on shares of Amedisys (NASDAQ:AMED – Get Free Report) in a research note issued on Wednesday. The firm set a “buy” rating on the health services provider’s stock. Amedisys Stock Performance NASDAQ AMED opened at $93.02 on Wednesday. The stock has a 50-day simple moving average of $94.29 and […]

Gotham Asset Management LLC increased its stake in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) by 6.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 75,536 shares of the health services provider’s stock after buying an additional 4,430 shares during the […]

Pentwater Capital Management LP grew its position in Amedisys, Inc. (NASDAQ:AMED – Free Report) by 239.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,144,000 shares of the health services provider’s stock after buying an additional 807,000 shares […]

AQR Arbitrage LLC boosted its stake in Amedisys, Inc. (NASDAQ:AMED – Free Report) by 407.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 314,321 shares of the health services provider’s stock after acquiring an additional 252,405 shares during the period. […]

Gotham Asset Management LLC raised its holdings in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) by 6.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 75,536 shares of the health services provider’s stock after acquiring an additional 4,430 shares during the quarter. […]

PNC Financial Services Group Inc. reduced its holdings in Amedisys, Inc. (NASDAQ:AMED – Free Report) by 19.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,672 shares of the health services provider’s stock after selling 1,593 shares during the quarter. PNC Financial […]

Amedisys (NASDAQ:AMED – Get Free Report) issued its quarterly earnings results on Wednesday. The health services provider reported $0.94 EPS for the quarter, missing analysts’ consensus estimates of $1.04 by ($0.10), Briefing.com reports. The business had revenue of $570.79 million for the quarter, compared to the consensus estimate of $566.85 million. Amedisys had a positive […]

Amedisys (NASDAQ:AMED – Get Free Report) announced its quarterly earnings results on Wednesday. The health services provider reported $0.94 EPS for the quarter, missing the consensus estimate of $1.04 by ($0.10), Briefing.com reports. The company had revenue of $570.79 million during the quarter, compared to analysts’ expectations of $566.85 million. Amedisys had a return on […]

StockNews.com initiated coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a research report report published on Saturday. The brokerage issued a buy rating on the health services provider’s stock. Amedisys Stock Down 0.2 % AMED stock opened at $95.02 on Friday. The company has a current ratio of 1.00, a quick ratio of […]

StockNews.com started coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a report published on Saturday. The firm issued a buy rating on the health services provider’s stock. Amedisys Stock Performance NASDAQ:AMED opened at $95.24 on Friday. The company has a current ratio of 1.00, a quick ratio of 1.00 and a debt-to-equity ratio […]